Tralance Addy is founder and President of Plebys International. Tralance led the acquisition of WHI by Plebys in 2002 and served as President and CEO of WHI from 2002-2009, during which time he led the transformation of the company from a technology-focused start-up to a new kind of service provider, focused on providing safe, affordable water to underserved communities. Prior to Plebys, Dr. Addy was an International Vice President of global health-care leader Johnson & Johnson (J&J). During his 20+ year career with J&J he held several other senior executive positions including Worldwide President of Advanced Sterilization Products (ASP), a Johnson & Johnson subsidiary he founded and established within the corporation. Tralance led the development, commercialization, and rapid growth of ASP to be a market segment leader covering over 40 countries around the world. He earlier was Vice President of R&D for Johnson & Johnson Medical, Inc., J&J’s Professional Sector subsidiary. He was a member of that company’s Global Management Committee.
In addition to his current board role with WHI, Tralance has served on the boards of Phyto-Riker Pharmaceuticals in Ghana, the Center for Sustainable Enterprise of UNC’s Kenan-Flagler Business School, the Sickle Cell Association of America, The United Way of Orange County, CA, Johns Hopkins Center for Talented Youth, and Swarthmore College’s Board of Managers. Tralance earned BA and BS degrees in chemistry and engineering simultaneously from Swarthmore College, Pennsylvania. He subsequently earned MS and PhD degrees in engineering from the University of Massachusetts at Amherst. He is a graduate of the Advanced Management Program of the Harvard Business School. He holds 14 U.S. and numerous international patents, from technology innovations and inventions developed over his career, and he is also a Fellow of the American Institute of Medical and Biological Engineering.